These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 10599912)
1. The use of barrier membranes and enamel matrix proteins in the treatment of angular bone defects. A prospective controlled clinical study. Pontoriero R; Wennström J; Lindhe J J Clin Periodontol; 1999 Dec; 26(12):833-40. PubMed ID: 10599912 [TBL] [Abstract][Full Text] [Related]
2. Periodontal tissue alterations following Emdogain treatment of periodontal sites with angular bone defects. A series of case reports. Heden G; Wennström J; Lindhe J J Clin Periodontol; 1999 Dec; 26(12):855-60. PubMed ID: 10599915 [TBL] [Abstract][Full Text] [Related]
3. A novel marginal periosteal pedicle graft as an autogenous guided tissue membrane for the treatment of intrabony periodontal defects. Gamal AY; Mailhot JM J Int Acad Periodontol; 2008 Oct; 10(4):106-17. PubMed ID: 19055224 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy of enamel matrix derivative in the treatment of intrabony defects: a 24-month multicenter study. Francetti L; Trombelli L; Lombardo G; Guida L; Cafiero C; Roccuzzo M; Carusi G; Del Fabbro M Int J Periodontics Restorative Dent; 2005 Oct; 25(5):461-73. PubMed ID: 16250568 [TBL] [Abstract][Full Text] [Related]
5. Microsurgical access flap and enamel matrix derivative for the treatment of periodontal intrabony defects: a controlled clinical study. Wachtel H; Schenk G; Böhm S; Weng D; Zuhr O; Hürzeler MB J Clin Periodontol; 2003 Jun; 30(6):496-504. PubMed ID: 12795787 [TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects. Heden G; Wennström JL J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257 [TBL] [Abstract][Full Text] [Related]
7. Expanded polytetrafluoroethylene and dental rubber dam barrier membranes in the treatment of periodontal intrabony defects. A comparative clinical trial. Paolantonio M; D'Archivio D; Di Placido G; Tumini V; Di Peppe G; Del Giglio Matarazzo A; De Luca M J Clin Periodontol; 1998 Nov; 25(11 Pt 1):920-8. PubMed ID: 9846802 [TBL] [Abstract][Full Text] [Related]
8. GTR treatment of degree III furcation defects following application of enamel matrix proteins. An experimental study in dogs. Araújo MG; Lindhe J J Clin Periodontol; 1998 Jun; 25(6):524-30. PubMed ID: 9667487 [TBL] [Abstract][Full Text] [Related]
9. Guided tissue regeneration in intrabony periodontal defects following treatment with two bioabsorbable membranes in combination with bovine bone mineral graft. A clinical and radiographic study. Vouros I; Aristodimou E; Konstantinidis A J Clin Periodontol; 2004 Oct; 31(10):908-17. PubMed ID: 15367197 [TBL] [Abstract][Full Text] [Related]
10. Enamel matrix proteins and guided tissue regeneration with titanium-reinforced expanded polytetrafluoroethylene membranes in the treatment of infrabony defects: a comparative controlled clinical trial. Zucchelli G; Bernardi F; Montebugnoli L; De SM J Periodontol; 2002 Jan; 73(1):3-12. PubMed ID: 11846197 [TBL] [Abstract][Full Text] [Related]
11. Clinical and radiographic findings following application of enamel matrix derivative in the treatment of intrabony defects. A series of case reports. Parashis A; Tsiklakis K J Clin Periodontol; 2000 Sep; 27(9):705-13. PubMed ID: 10983605 [TBL] [Abstract][Full Text] [Related]
12. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study. Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918 [TBL] [Abstract][Full Text] [Related]
13. Enamel matrix proteins in the treatment of deep intrabony defects. Cardaropoli G; Leonhardt AS J Periodontol; 2002 May; 73(5):501-4. PubMed ID: 12027251 [TBL] [Abstract][Full Text] [Related]
14. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study. Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541 [TBL] [Abstract][Full Text] [Related]
15. Treatment of deep and shallow intrabony defects. A multicenter randomized controlled clinical trial. Cortellini P; Carnevale G; Sanz M; Tonetti MS J Clin Periodontol; 1998 Dec; 25(12):981-7. PubMed ID: 9869347 [TBL] [Abstract][Full Text] [Related]
16. Enamel matrix proteins in the treatment of intra-bony defects. A prospective 24-month clinical trial. Francetti L; Del Fabbro M; Basso M; Testori T; Weinstein R J Clin Periodontol; 2004 Jan; 31(1):52-9. PubMed ID: 15058375 [TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane. Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417 [TBL] [Abstract][Full Text] [Related]
18. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series. Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103 [TBL] [Abstract][Full Text] [Related]
19. Combination use of bovine porous bone mineral, enamel matrix proteins, and a bioabsorbable membrane in intrabony periodontal defects in humans. Lekovic V; Camargo PM; Weinlaender M; Kenney EB; Vasilic N J Periodontol; 2001 May; 72(5):583-9. PubMed ID: 11394392 [TBL] [Abstract][Full Text] [Related]
20. Enamel matrix derivative (EMDOGAIN) in the treatment of intrabony periodontal defects. Heijl L; Heden G; Svärdström G; Ostgren A J Clin Periodontol; 1997 Sep; 24(9 Pt 2):705-14. PubMed ID: 9310876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]